Trial Profile
A European, multicentre, efficacy and safety study of I10E in initial and maintenance treatments of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Jun 2016
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Adverse reactions; Therapeutic Use
- Acronyms PRISM I
- Sponsors LFB Biotechnologies
- 30 Mar 2015 New trial record